Shilpa Gupta, MD – From Fellowship to Leadership in GU Oncology Research

Shilpa Gupta, MD, is the director of genitourinary medical oncology at the Taussig Cancer Institute and co-leader of the Genitourinary Oncology Program at the Cleveland Clinic. Throughout her career, she has pioneered research initiatives that led to the development of novel therapeutics and biomarkers for optimizing patient outcomes in GU cancers, with a focus on bladder cancer.

We spoke with Dr. Gupta to trace the trajectory of her impactful career in GU oncology, from her early research endeavors to her current leadership positions at the Cleveland Clinic.

Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

Expert Interviews

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Conference Coverage

Live meeting highlights

Julian Chavarriaga, MDTesticular, Penile, and Rare Malignancies | April 12, 2024
Dr. Julian Chavarriaga describes his study on using miRNA as a liquid biomarker to detect malignancy in testicular masses.
Read More
Marco Finati, MDProstate Cancer | April 9, 2024
Dr. Finati discusses what the future has in store for further investigation utilizing larger patient databases.
Guy Verhovsky, MDUrothelial Carcinoma | April 11, 2024
Drs. Grasso and Verhovsky discuss the potential of endoscopic treatment with surveillance for patients with bladder cancer.
Amanda Myers, MDNon-Muscle Invasive Urothelial Carcinoma | April 9, 2024
Dr. Myers and colleagues challenge the current paradigm of discouraging additional BCG therapy for "unresponsive" NMIBC.

Video Insights

Clinical discussions with experts in the field

Network Websites